NTH.MC BME
Naturhouse Health, S.A.
1W: -10.2%
1M: -11.3%
3M: -13.4%
YTD: -13.4%
1Y: +21.6%
3Y: +50.7%
5Y: +81.8%
€2.20 ($2.48)
-0.11 (-4.76%)
Weekly Expected Move ±4.6%
€2
€2
€2
€2
€2
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Income Trends
Revenue
$49M
-1.9% ▼
5Y CAGR: -9.6%
Gross Profit
$35M
+41.2% ▲
5Y CAGR: -9.3%
Operating Income
$13M
-19.2% ▼
5Y CAGR: -7.3%
Net Income
$10M
-12.7% ▼
5Y CAGR: -5.7%
EPS (Diluted)
$0.16
-15.8% ▼
5Y CAGR: -6.2%
EBITDA
$16M
-12.8% ▼
5Y CAGR: -7.9%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $55M | $58M | $52M | $50M | $49M |
| YoY Growth | -32.6% | +4.6% | -9.0% | -3.8% | -1.9% |
| Cost of Revenue | $32M | $17M | $15M | $25M | $14M |
| Gross Profit | $39M | $41M | $37M | $25M | $35M |
| Gross Margin | 70.7% | 71.6% | 71.5% | 49.8% | 71.8% |
| R&D Expenses | $32K | $8K | $8K | $4K | $24K |
| SG&A Expenses | $11M | $10M | $11M | $13M | $10M |
| Operating Expenses | $26M | $24M | $25M | $20M | $22M |
| Operating Income | $13M | $17M | $13M | $16M | $13M |
| Operating Margin | 24.0% | 30.1% | 24.5% | 32.3% | 26.6% |
| Interest Expense | $185K | $100K | $206K | $107K | $139K |
| Income Before Tax | $14M | $18M | $13M | $15M | $14M |
| Tax Expense | $4M | $5M | $3M | $4M | $4M |
| Net Income | $9M | $13M | $10M | $11M | $10M |
| Net Margin | 17.0% | 23.2% | 18.4% | 22.4% | 20.0% |
| EPS (Diluted) | $0.16 | $0.22 | $0.16 | $0.19 | $0.16 |
| EBITDA | $17M | $21M | $16M | $18M | $16M |
| Shares Outstanding | 60M | 60M | 60M | 60M | 60M |